Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > No quarterly update?

<< Previous

Bullboard Posts

Next >>

Comment by forhandlarenon Jul 17, 2024 12:49am

162 Views

Post# 36136064

RE:RE:RE:No quarterly update?

I think there's basically two options.

a) Abbvie launch skin lightening products in January and we have to wait 6 months.

I'm pretty sure that management have said that TFC-1067 should not be used when the skin is exposed for strong sun and therefore I didn't expect a launch this summer.

One reason why Sirona Biochem decided to launch the anti-aging themselves is to master the planning in contrast (to Abbvie).

b) Abbvie has decided to shelve it, maybe because the existing line is doing well in the market.

Contract details is not disclosed, but from what I've heard Abbvie will pay if they don't launch. Possibly an annual royalty tied to a calculated baseline. The financial reports does not include Abbvie penalty payment so I think the launch window is still open.